Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take "several years." ...

The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...

Lorde says MDMA therapy cured her stage fright. Here's what to know about the controversial mental health treatment.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).

The recent FDA decision on the use of MDMA for PTSD treatment has created uncertainty about the future of psychedelic therapy. Learn more about the implications and potential impact on patients.

The Trump administration shows interest in psychedelic research for treating PTSD and mental health disorders, as clinical trials demonstrate potential benefits of MDMA and psilocybin.

Driven by a desire to help ex-servicemembers with post-traumatic stress disorder and other mental illnesses, GOP lawmakers ...

Contrary to some prior research, MDMA use was not associated with reduced anxiety or PTSD symptoms: Survivors who had consumed either MDMA or no psychedelics exhibited higher levels of these symptoms.

Though caution is required when the data haven't been published, it could be a landmark in the drug's journey toward FDA ...

Compared to nonmilvet samples, military and veteran participants exhibited lower proportions of diagnosis loss after cognitive processing therapy.

A new study conducted by researchers from Reichman University and other Israeli institutions explored the psychological aftermath of the deadly terrorist attack at the Nova Festival in southern ...